A Shc313F-like signature displays a modestly higher correlation with CD8A (R=0.26) and PD-L1 levels (R=0.28) compared with tumours with an enhanced 2F-like response (R=0.22 and R=0.15, respectively). This evidence concerns the gene CD8A and neoplasm.